药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Potassium cation
Safrazine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Safrazine.
Potassium cation
Pivhydrazine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Pivhydrazine.
Potassium cation
Phenoxypropazine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Phenoxypropazine.
Potassium cation
Pheniprazine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Pheniprazine.
Potassium cation
Octamoxin
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Octamoxin.
Potassium cation
Mebanazine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Mebanazine.
Potassium cation
Iproclozide
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Iproclozide.
Potassium cation
Benmoxin
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Benmoxin.
Potassium cation
Toloxatone
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Toloxatone.
Potassium cation
Pirlindole
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Pirlindole.
Potassium cation
Hydracarbazine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Hydracarbazine.
Potassium cation
Brilaroxazine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Brilaroxazine.
Potassium cation
Zotepine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Zotepine.
Potassium cation
Melperone
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Melperone.
Potassium cation
Blonanserin
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Blonanserin.
Potassium cation
Etoperidone
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Etoperidone.
Potassium cation
Talopram
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Talopram.
Potassium cation
Lortalamine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Lortalamine.
Potassium cation
Nisoxetine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Nisoxetine.
Potassium cation
Viloxazine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Viloxazine.